Phibro Animal Health (PAHC) Deferred Taxes (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Deferred Taxes of $3.7 million for Q1 2026, up 692.07% year-over-year from $461953.4 in Q1 2025, and down 4.66% quarter-over-quarter from $3.8 million in Q4 2025.
Phibro Animal Health (PAHC) Deferred Taxes (2013 - 2026) Analysis & Trends
Phibro Animal Health's Deferred Taxes history runs 14 years deep, the most recent figure standing at $3.7 million for Q1 2026.
- In Q1 2026, Deferred Taxes rose 692.07% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $18.0 million (up 197.58% YoY), while the FY2025 annual figure was -$4.9 million, up 59.48% from the prior year.
- Deferred Taxes for Q1 2026 stood at $3.7 million, down from $3.8 million in the prior quarter.
- The five-year high for Deferred Taxes was $8.4 million in Q2 2025, with the low at -$7.7 million in Q4 2024.
- The 5-year median for Deferred Taxes is -$300000.0 (2024), against an average of -$609411.8.
- The sharpest annual moves came in 2023 and 2026: Deferred Taxes tumbled 20600.0% in 2023, then soared 692.07% in 2026.
- Phibro Animal Health's Deferred Taxes stood at -$108000.0 in 2022, then tumbled by 3432.41% to -$3.8 million in 2023, then plunged by 102.88% to -$7.7 million in 2024, then soared by 149.59% to $3.8 million in 2025, then retreated by 4.66% to $3.7 million in 2026.
- Business Quant data shows PAHC's Deferred Taxes at $3.7 million in Q1 2026, $3.8 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 3.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.66 Mn |
| Dec 31, 2025 | 3.84 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 8.36 Mn |
| Mar 31, 2025 | -618,000.00 |
| Dec 31, 2024 | -7.74 Mn |
| Sep 30, 2024 | -4.88 Mn |
| Jun 30, 2024 | -5.24 Mn |
| Mar 31, 2024 | -300,000.00 |
| Dec 31, 2023 | -3.82 Mn |
| Sep 30, 2023 | -2.69 Mn |
| Jun 30, 2023 | -3.07 Mn |
| Mar 31, 2023 | 356,000.00 |
| Dec 31, 2022 | -108,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | -686,000.00 |
| Mar 31, 2022 | 417,000.00 |
| Dec 31, 2021 | -506,000.00 |
| Sep 30, 2021 | -31,000.00 |
| Jun 30, 2021 | -2.20 Mn |